𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase II clinical and pharmacological study of didemnin B in patients with metastatic breast cancer

✍ Scribed by John A. Benvenuto; Robert A. Newman; Gary S. Bignami; T. J. G. Raybould; Martin N. Raber; Laura Esparza; Ronald S. Walters

Publisher
Springer US
Year
1992
Tongue
English
Weight
342 KB
Volume
10
Category
Article
ISSN
0167-6997

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Phase II study of ionidamine in patients
Phase II study of ionidamine in patients with metastatic breast cancer
✍ H. Ian Robins; Donna S. Neuberg; Al B. Benson; Kishan J. Pandya; Douglass C. Tor πŸ“‚ Article πŸ“… 1990 πŸ› Springer US 🌐 English βš– 193 KB

The Eastern Cooperative Oncology Group conducted a phase II study of lonidamine in patients with metastatic breast cancer. The drug was given orally to a maximum daily dose of 340 mg/m 2. Forty-two patients were entered on study. One partial response was observed; there were no life-threatening toxi

Phase II study of flutamide in patients
Phase II study of flutamide in patients with metastatic breast cancer. A National Cancer Institute of Canada Clinical Trials Group study
✍ Daniele J. Perrault; Diane M. Logan; David J. Stewart; Vivien H. C. Bramwell; Al πŸ“‚ Article πŸ“… 1988 πŸ› Springer US 🌐 English βš– 271 KB

The National Cancer Institute of Canada (NCIC) Clinical Trials Group conducted a phase II study of the oral antiandrogen flutamide in 33 patients with metastatic breast cancer. Eight patients had received no prior systemic therapy for their metastatic disease and 13 had only one site of metastasis.

Clinical significance of circulating imm
Clinical significance of circulating immune complexes in patients with metastatic breast cancer
✍ G. Krieger; A. Kehl; H.-E. Wander; A.-M. Salo; H. F. Rauschecker; G. A. Nagel πŸ“‚ Article πŸ“… 1983 πŸ› John Wiley and Sons 🌐 French βš– 541 KB

## Abstract Serum circulating immune complexes (CIC) were repeatedly measured by means of the Cl binding assay (Cba) and the Raji cell assay (Rca) in 158 patients with metastatic breast cancer (mbc). Frequency of occurrence and levels of CIC were only slightly increased in mbc when compared to age‐